Postoperative infection occurred in 10% of the implantations. However, few of these were severe. Staphylococcus aureus was the most common pathogen and the presence of biofilm seemed to be associated with a higher risk of explantation.

Conclusion: The rate of severe complications was low and cochlear implantation is a relatively safe procedure. Standardization is crucial when reporting on cochlear implant complications to ensure comparability between studies. A consensus on the reporting of complications proposed by a Danish team of researchers was applied, evaluated and found beneficial.Objectives:To report the surgical complications following cochlear implantation at our centre, applying and evaluating a proposed reporting consensus.Methods:A retrospective file review of 308 consecutive adult implantations in 269 patients between 1994 and 2010 at Odense University Hospital was performed.Results:The three most common major complications were wound infection (1.6%), permanent chorda tympani syndrome (1.6%) and electrode migration/misplacement/accidental removal (1.3%). Permanent facial nerve paresis occurred following one implantation (0.3%). Transient chorda tympani syndrome (30.8%), vertigo/dizziness (29.5%) and tinnitus (4.9%) were the most frequent minor complications.

A general postoperative decrease in salivary secretion could not be found. However, a 29.9% mean reduction in non-stimulated salivary flow was observed when looking specifically at the visit the day after surgery (p = 0.001). When adjusting for perioperative administration of glycopyrrolate (p < 0.001) and atropine (p = 0.178), the former was highly associated with a 69.7% mean decrease in non-stimulated salivary flow at the visit the day after surgery. The third examination was still, independent of glycopyrrolate administration, borderline significantly associated with a 14.5% mean decrease (p = 0.054). We did not find any significant decrease in sense of taste following implantation.

The results of various forms of primary treatment of cancer of the vulva during the decade 1958‐1968 in the Radium Centre, Århus Municipal Hospital, University of Århus, are submitted. The series consists of 67 patients classified by the T‐N‐M system (U.I.C.C. 1967). Comparison of 29 patients treated by vulvectomy and node dissection with 26 patients treated by less extensive surgery without node dissection showed a 19% higher corrected 4 year survival and a 14% lower nodal recurrence rate in the former group although according to the T‐N‐M classification it must be presumed to have contained rather more advanced cancers. There was quite a marked difference between the clinical assessment of the regional lymph nodes and the histological findings at dissection. This applied to the histologically positive as well as negative lymph nodes. A review of the literature shows that the present results are in keeping with previous publications which have shown that the treatment of choice in cancer of the vulva is still total vulvectomy with routine dissection of the superficial and deep inguinal lymph nodes, supplemented by dissection of the iliac lymph nodes, if histological examination during the operation shows positive lymph nodes in the inguinal region.